Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06068751
Other study ID # 139
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 22, 2023
Est. completion date December 31, 2023

Study information

Verified date September 2023
Source Gaziosmanpasa Research and Education Hospital
Contact Rabia Likos, MD
Phone +902129453000
Email rabialikos@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled single-blind trial will include 60 pediatric migraine patients. Participants will be divided into two groups: one performing aerobic exercise, and the other conducting neck exercises. Assessments include attack frequency, severity, duration, and neck pain over three months.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria: - Pediatric Migraneurs, as per International Classification of Headache Disorders-3 guidelines Exclusion Criteria: - individuals with any other concomitant headaches - those showing findings beyond nonspecific hyperintense areas on cranial Magnetic Resonance Imaging - patients with systemic diseases other than migraine, such as fibromyalgia - individuals who had experienced treatment changes or required treatment changes within the last month - limited mental capacity or psychological illnesses that could hinder their participation in surveys and exercises - a history of increased attack frequency or severity with previous physical activity program involvement, or a history of trauma to the neck or face - individuals with a history of a herniated disc in the cervical region or symptoms of cervical radiculopathy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aerobic Exercise
The initial group will receive instructions to increase their moderate to high-intensity physical activity frequency to at least 60 minutes per day (in episodes exceeding 10 minutes) by 50%, with a minimum of three days per week. They will be encouraged to engage in enjoyable and age-appropriate activities, including jogging, brisk walking, swimming, dancing, cycling, as well as sports like basketball, football, and tennis.
Neck Exercises
The second group, focused on neck exercises, will receive guidance from an experienced physiotherapist and their families. The physiotherapist will demonstrate a series of stretching and isometric strengthening exercises for specific muscle groups: upper trapezius, levator scapula, sternocleidomastoid, cervical flexors, and extensors, which have been associated with migraines in prior studies. Each patient will perform 3 sets of 10-15 repetitions for both stretching and isometric strengthening exercises per muscle group, with a 1-minute break between sets. Patients will be advised to maintain a gentle stretch during stretching exercises, avoiding excessive force to prevent discomfort. Static stretching and isometric strengthening exercises will involve holding each position for 5-10 seconds. In the initial week, a reduced set of 5 repetitions will be allowed for adaptation. Throughout the intervention, participants will follow this exercise regimen for 3 days weekly.

Locations

Country Name City State
Turkey Gaziosmanpasa Research and Training Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Gaziosmanpasa Research and Education Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Migraine Attack Frequency The frequency of migraine attacks in patients will be evaluated in days/month. Baseline, first and third month follow-ups
Primary Migraine Attack Duration The duration of attacks in patients will be recorded in hours. Baseline, first and third month follow-ups
Primary Migraine Attack Severity The severity of migraine attacks will be assessed using a visual analog scale, and a score between 0 and 10 will be assigned. A high score indicates more severe attack. Baseline, first and third month follow-ups
Primary Neck Pain Severity The severity of neck pain will be assessed using a visual analog scale, and a score between 0 and 10 will be assigned. A high score indicates severe pain. Baseline, first and third month follow-ups
See also
  Status Clinical Trial Phase
Terminated NCT03885154 - Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine Phase 2
Recruiting NCT05814497 - Supraspinal Processing of Sensory Aspects of Pain N/A
Not yet recruiting NCT06277063 - nVNS for the Prevention and Treatment of Primary Headache N/A
Recruiting NCT03984045 - SPG Block for Acute Pediatric Migraine Phase 3
Recruiting NCT06182098 - Intravenous Fluids in Pediatric Migraine N/A
Completed NCT03806595 - A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine Phase 1
Completed NCT04968093 - Mindfulness for Adolescents for CM and HFEM N/A
Withdrawn NCT04466826 - Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients Phase 2
Recruiting NCT05969990 - Tryptophan Metabolites in Pediatric Migraine
Not yet recruiting NCT06180577 - A Survey Study to Assess the Accessibility of the Nerivio Device at School
Completed NCT04537429 - A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab Phase 1